Empleo, Khent Lior G.

HRN: 20-09-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFTRIAXONE 1G (VIAL)
08/17/2022
08/24/2022
IV
350mg
Q12
UTI
Waiting Final Action 
08/17/2022
CEFTRIAXONE 1G (VIAL)
08/17/2022
08/24/2022
IV
900 Mg
Q24H
Lymphaneditis, Cannot Totally RO Kawasaki; PCAP C
Waiting Final Action 
08/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/17/2022
08/24/2022
IV
95mg
Q8H
Lymphadenitis Cannot Totally RO Kawasaki; PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: